The Huntington’s disease genetic testing market will touch USD 28.3 million, advancing at a 3.1% compound annual growth rate, by 2030. This is because of the decreasing price of genetic tests, the high incidence of Huntington’s disease, and the tactics taken by private and public administration to raise consciousness regarding HD.

Moreover, the accessibility of different kinds of genetic tests, coupled with the existence of an enormous middle-aged populace is also assisting the industry expansion. Furthermore, because of the rising emphasis of researchers on producing new technologies, numerous private and public organizations are organizing conferences and associated events to raise consciousness regarding Huntington’s disease.

The industry has been observing an increase in the advancement and introduction of genetic tests as well as testing kits. Many health organizations, institutes, and companies around the globe are concentrating on research programs to develop innovative genetic testing kits for Huntington’s disease.

In the past few years, the adult category, on the basis of patient group, was the largest contributor to the Huntington’s disease genetic testing market. Moreover, This category will further observe a healthy compound annual growth rate, during this decade. This can be primarily because Huntington’s disease is highly common in adults, particularly people between the ages of 30 to 50, who demonstrate the highest Huntington’s disease occurrence.

The male category, on the basis of patient gender, was the higher revenue contributor to the industry, in the past few years. This can be primarily ascribed to the slightly greater incidence of genetic disorders in the male populace in many of the key nations. Moreover, this fact is visible where the incidence of Huntington’s disease is extremely high. This category will further advance at a faster compound annual growth rate in the years to come.

In recent years, North America was the largest contributor to the industry. This is primarily because of the existence of reputable players in the U.S., coupled with the high incidence of genetic disorders in this continent. Moreover, the presence of a large number of settings where genetic testing is performed, and high healthcare expenses are also important factors for the dominance of the regional industry.

North America is also likely to observe the fastest compound annual growth rate in the years to come. This is primarily ascribed to the mounting elderly population, rising research on genetic illnesses, coupled with the increasing number of companies providing complete genetic testing services in the U.S.


SOURCE: P&S Intelligence